Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00176579 · ClinicalTrials.gov registry record
Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer
A clinical trial of Prostate Cancer and Osteoporosis, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- 27
- Enrollment target
- 1
- Study location
NCT00176579: Completed study of Prostate Cancer and Osteoporosis, sponsored by University of Medicine and Dentistry of New Jersey.
NCT00176579 is a study of Prostate Cancer and Osteoporosis that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 27 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00176579, a study of Prostate Cancer and Osteoporosis, has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Measuring bone mineral density may help doctors predict whether prostate cancer will come back. It may also help the study of prostate cancer in the future. PURPOSE: This clinical trial is studying whether bone mineral density affects cancer recurrence in patients with early stage prostate cancer.
Primary Outcome
DXA scan will be done after patient signs consent and eligibilty is confirmed
Conditions Studied
Interventions
- PROCEDURE dual x-ray absorptiometry
Study Locations (1)
New Jersey
- Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2003-06 |
| Est. Completion | 2008-07 |
What the finished NCT00176579 record still lists
NCT00176579 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which dual x-ray absorptiometry is the first listed.
NCT00176579 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT00176579 about?
NCT00176579 is a clinical study titled "Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer". RATIONALE: Measuring bone mineral density may help doctors predict whether prostate cancer will come back. It may also help the study of prostate cancer in the future. PURPOSE: This clinical trial is studying whether bone mineral density affects cancer recurrence in patients with early stage prosta...
What is the current status of trial NCT00176579?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2003-06. Estimated completion is 2008-07.
What conditions does trial NCT00176579 study?
This clinical trial studies the following conditions: Prostate Cancer, Osteoporosis.
What interventions are being tested in trial NCT00176579?
The interventions under investigation include: dual x-ray absorptiometry (PROCEDURE).
Who is sponsoring clinical trial NCT00176579?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00176579 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00176579's enrollment target sits among peer trials
27 615th of 735 higher than 114 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
RECRUITING
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia